Bayer Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 34.24 Cr
as on 23-10-2024
- Paid Up Capital ₹ 21.32 Cr
as on 23-10-2024
- Company Age 26 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.40 Cr
as on 23-10-2024
- Revenue 25.04%
(FY 2023)
- Profit -21.58%
(FY 2023)
- Ebitda -23.34%
(FY 2023)
- Net Worth -34.35%
(FY 2023)
- Total Assets -8.61%
(FY 2023)
About Bayer Pharmaceuticals
The Corporate was formerly known as Bayer Zydus Health Care Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 34.24 Cr and a paid-up capital of Rs 21.32 Cr.
The company has closed loans amounting to ₹7.40 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Bayer Pharmaceuticals Private Limited India is Deepika Patil as COMPANY SECRETARY. Shweta Rai and Kunal Jha serve as directors at the Company.
- CIN/LLPIN
U05195MH1998PTC116021
- Company No.
116021
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jul 1998
- Date of AGM
10 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bayer Pharmaceuticals Private Limited offer?
Bayer Pharmaceuticals Private Limited offers a wide range of products and services, including Healthcare Devices, Diabetes Monitors, Devices, Test Strips & Lancets.
Who are the key members and board of directors at Bayer Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepika Patil | Company Secretary | 07-May-2024 | Current |
Shweta Rai  | Managing Director | 11-Jan-2024 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kunal Jha | Director | 28-Mar-2024 | Current |
Financial Performance and Corporate Structure Insights of Bayer Pharmaceuticals.
Bayer Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.04% increase. The company also saw a substantial fall in profitability, with a 21.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 34.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bayer Pharmaceuticals?
In 2023, Bayer Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bayer Zydus Pharma Private LimitedActive 13 years 10 monthsShweta Rai and Kunal Jha are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Dec 2000 | ₹3.00 Cr | Satisfied |
Union Bank Of India Creation Date: 13 Nov 2000 | ₹4.00 Cr | Satisfied |
Union Bank Of India Creation Date: 13 Nov 2000 | ₹4.00 M | Satisfied |
How Many Employees Work at Bayer Pharmaceuticals?
Bayer Pharmaceuticals has a workforce of 332 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bayer Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bayer Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
